Xiaoyong Fu

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Journal of biophotonics

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

Endocrinology

Baylor College of Medicine

Second Military Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Baylor College of Medicine Jul 01 2015

United States

Assistant Professor :: Molecular and Cellular Biology

Education History

Second Military Medical University Sep 01 1998 - Jul 01 2003

China

PHD :: Eastern Hepatobiliary Surgery Institute

Publications

Agostina Nardone, Xintao Qiu, Sándor Spisák, Zsuzsanna Nagy, Ariel Feiglin, Avery Feit, Gabriella Cohen, Yingtian Xie, Alba Font-Tello, Cristina Guarducci, Francisco Hermida-Prado, Sudeepa Syamala, Klothilda Lim, Miguel Munoz Gomez, Matthew Pun, MacIntosh Grant Cornwell, Weihan Liu, Aysegul Ors, Hisham Mohammed, Paloma Cejas, Jane B Brock, Matthew L Freedman, Eric P Winer, Xiaoyong Fu, Rachel Schiff, Henry W Long, Otto Metzger Filho, Rinath M Jeselsohn
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer. Cancer research 82 (20) (2022)
Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Vidyalakshmi Sethunath, Nicholas Wang, Susan G Hilsenbeck, Matteo Benelli, Ilenia Migliaccio, Cristina Guarducci, Luca Malorni, Lacey M Litchfield, Jiangang Liu, Joshua Donaldson, Pier Selenica, David N Brown, Britta Weigelt, Jorge S Reis-Filho, Ben H Park, Sara A Hurvitz, Dennis J Slamon, Mothaffar F Rimawi, Valerie M Jansen, Rinath M Jeselsohn, C Kent Osborne, Rachel Schiff
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Xiaoyong Fu, Carmine De Angelis, Rachel Schiff
Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic. Endocrinology 163 (1) (2021)
Mingjun Bi, Zhao Zhang, Yi-Zhou Jiang, Pengya Xue, Hu Wang, Zhao Lai, Xiaoyong Fu, Carmine De Angelis, Yue Gong, Zhen Gao, Jianhua Ruan, Victor X Jin, Elisabetta Marangoni, Elodie Montaudon, Christopher K Glass, Weibo Xie, Tim Hui-Ming Huang, Zhi-Ming Shao, Rachel Schiff, Lizhen Chen, Zhijie Liu
Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. Nature cell biology 22 (6) (2020)
Nrusingh C Biswal, Xiaoyong Fu, Jaidip M Jagtap, Martin J Shea, Vijetha Kumar, Tamika Lords, Ronita Roy, Rachel Schiff, Amit Joshi
In vivo longitudinal imaging of RNA interference-induced endocrine therapy resistance in breast cancer. Journal of biophotonics 13 (1) (2019)
Xiaoyong Fu, Resel Pereira, Carmine De Angelis, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Maria L Cataldo, Vidyalakshmi Sethunath, Sepideh Mehravaran, Carolina Gutierrez, Gary C Chamness, Qin Feng, Bert W O'Malley, Pier Selenica, Britta Weigelt, Jorge S Reis-Filho, Ofir Cohen, Nikhil Wagle, Agostina Nardone, Rinath Jeselsohn, Myles A Brown, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer. Proceedings of the National Academy of Sciences of the United States of America (2019)

Xiaoyong Fu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiaoyong Fu